UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.243

Sortiert nach

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Nature communications, 2018-11, Vol.9 (1), p.4664-5, Article 4664

2018

Volltextzugriff (PDF)

Incidence of T790M mutation in (sequential) rebiopsies in EGFR -mutated NSCLC-patients

Lung cancer (Amsterdam, Netherlands), 2014-07, Vol.85 (1), p.19-24

2014

Volltextzugriff (PDF)

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

Annals of oncology, 2014-08, Vol.25 (8), p.1475-1484

2014

Volltextzugriff (PDF)

Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis

Annals of oncology, 2013-06, Vol.24 (6), p.1543-1548

2013

Volltextzugriff (PDF)

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

Annals of oncology, 2006-11, Vol.17 (11), p.1698-1704

2006

Volltextzugriff (PDF)

Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT

European journal of clinical nutrition, 2012-03, Vol.66 (3), p.399-404

2012

Volltextzugriff (PDF)

High-dose, pulsatile erlotinib in two NSCLC patients with leptomeningeal metastases—One with a remarkable thoracic response as well

Lung cancer (Amsterdam, Netherlands), 2013-04, Vol.80 (1), p.102-105

2013

Volltextzugriff (PDF)

EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?

Lung cancer (Amsterdam, Netherlands), 2014-04, Vol.84 (1), p.86-91

2014

Volltextzugriff (PDF)

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach

British journal of cancer, 2015-03, Vol.112 (6), p.1105-1113

2015

Volltextzugriff (PDF)

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study

Annals of oncology, 2011-07, Vol.22 (7), p.1520-1527

2011

Volltextzugriff (PDF)

Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment

European journal of cancer (1990), 2011-11, Vol.47 (17), p.2603-2606

2011

Volltextzugriff (PDF)

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2007-03, Vol.99 (6), p.442-450

2007

Volltextzugriff (PDF)

Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression

PloS one, 2017-08, Vol.12 (8), p.e0182885-e0182885

2017

Volltextzugriff (PDF)

Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial

British journal of cancer, 2014-05, Vol.110 (10), p.2427-2433

2014

Volltextzugriff (PDF)

Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy

The European respiratory journal, 2009-08, Vol.34 (2), p.371-379

2009

Volltextzugriff (PDF)

Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2010-05, Vol.878 (15), p.1059-1068

2010

Volltextzugriff (PDF)

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv192-iv237

2018

Volltextzugriff (PDF)

Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer

European journal of cancer (1990), 2022-08, Vol.171, p.114-123

2022

Volltextzugriff (PDF)

Advantages of decellularized bovine pericardial scaffolds compared to glutaraldehyde fixed bovine pericardial patches demonstrated in a 180-day implant ovine study

Cell and tissue banking, 2022-12, Vol.23 (4), p.791-805

2022

Volltextzugriff (PDF)

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Annals of oncology, 2023-04, Vol.34 (4), p.339-357

2023

Volltextzugriff (PDF)

How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer

Annals of oncology, 2019-06, Vol.30 (6), p.884-896

2019

Volltextzugriff (PDF)

Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study

EJNMMI research, 2020-08, Vol.10 (1), p.97-97, Article 97

2020

Volltextzugriff (PDF)

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study

Annals of oncology, 2013-11, Vol.24 (11), p.2860-2865

2013

Volltextzugriff (PDF)

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Annals of oncology, 2023-04, Vol.34 (4), p.358-376

2023

Volltextzugriff (PDF)

Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension

The European respiratory journal, 2008-06, Vol.31 (6), p.1160-1166

2008

Volltextzugriff (PDF)

1 – 25 von 2.243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.041)
Mit Volltextzugriff
(2.013)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.558)
Life Sciences & Biomedicine
(1.159)
Humans
(1.059)
Male
(701)
Female
(687)
Biological And Medical Sciences
(547)
Middle Aged
(514)
Medical Sciences
(476)
Aged
(400)
Adult
(391)
Physical Sciences
(298)
Oncology
(275)
Technology
(242)
Remote Sensing
(174)
Animals
(162)
Risk Factors
(161)
Imaging Science & Photographic Technology
(152)
Geography, Physical
(150)
Physical Geography
(150)
Treatment Outcome
(140)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Incidence of T790M mutation in (sequential) rebiopsies in EGFR -mutated NSCLC-patients

2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT

High-dose, pulsatile erlotinib in two NSCLC patients with leptomeningeal metastases—One with a remarkable thoracic response as well

EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III study

Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression

Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial

Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy

Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer

Advantages of decellularized bovine pericardial scaffolds compared to glutaraldehyde fixed bovine pericardial patches demonstrated in a 180-day implant ovine study

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer

Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study

Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension

Suchergebnisse filtern